Filter
2425
Filtered Results: 2425
Text search:
National
Institute
of
Environmental
Health
Sciences
Featured
Recommendations
185
New Publications
579
Language
Document type
No document type
1263
Studies & Reports
584
Guidelines
279
Manuals
136
Strategic & Response Plan
81
Training Material
35
Fact sheets
23
Situation Updates
14
Resource Platforms
6
Brochures
1
App
1
Infographics
1
Online Courses
1
Countries / Regions
India
152
Global
109
Kenya
67
South Africa
57
Africa
51
Ethiopia
46
Nigeria
44
Nepal
42
Western and Central Europe
42
Uganda
41
Latin America and the Carribbean
39
Ghana
38
Rwanda
37
Liberia
36
Malawi
36
Sierra Leone
33
Tanzania
27
Philippines
26
Namibia
25
Myanmar / Burma
22
Bangladesh
21
Zambia
20
South–East Asia Region
19
Syria
18
Asia
18
Congo, Democratic Republic of
15
Ukraine
15
Botswana
14
Guinea
13
Brazil
13
Eastern Europe
13
Zimbabwe
12
Germany
12
Cambodia
12
Senegal
11
South Sudan
11
Indonesia
11
Russia
10
Cameroon
9
Mozambique
9
Lesotho
9
West and Central Africa
9
Western Pacific Region
9
Burkina Faso
8
USA
8
Pakistan
8
Thailand
8
Middle East and North Africa
8
East and Southern Africa
7
Vietnam
7
Sudan
6
Eswatini/ Swaziland
6
Colombia
6
Eastern Europe and Central Asia
6
China
5
Benin
5
Chile
5
Venezuela
5
Mali
4
Haiti
4
Jordan
4
Lebanon
4
Turkey
4
Southern Africa
4
Somalia
3
Afghanistan
3
Peru
3
North Macedonia
3
Yemen
3
Albania
3
Laos
3
Tajikistan
3
North America
3
United Kingdom
3
Spain
3
Côte d’Ivoire / Ivory Coast
2
Iraq
2
Chad
2
Central African Republic
2
Ecuador
2
Angola
2
Sri Lanka
2
Moldova
2
Iran
2
Kyrgyzstan
2
Kazakhstan
2
Japan
2
Portugal
2
Bosnia and Herzegovina
2
Guinea-Bissau
1
Morocco
1
Saudi Arabia
1
Togo
1
Gambia
1
Malaysia
1
Papua New Guinea
1
Argentina
1
Honduras
1
Bolivia
1
Greece
1
Guatemala
1
Paraguay
1
Bhutan
1
Canada
1
Qatar
1
Lithuania
1
Georgia
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
839
Public Health
167
Clinical Guidelines
143
Key Resources
124
Women & Child Health
103
Capacity Building
30
Pharmacy & Technologies
29
Annual Report MEDBOX
1
Toolboxes
Planetary Health
231
Mental Health
226
COVID-19
146
HIV
134
AMR
114
Disability
109
TB
88
Global Health Education
82
Caregiver
78
NTDs
73
NCDs
67
Rapid Response
55
Ebola
47
Pharmacy
45
Conflict
31
Specific Hazards
30
Natural Hazards
28
Refugee
27
Health Financing Toolbox
18
Social Ethics
14
Polio
9
Zika
9
Cholera
7
South Sudan
1
Provides clinical descriptions, diagnostic guidelines, and codes for all mental and behavioural disorders commonly encountered in clinical psychiatry. The book was developed from chapter V of the Tenth Revision ... the International Statistical Classification of Diseases and Related Health Problems (ICD-10).
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
This European compendium was produced to provide operational examples of the new nursing and midwifery roles and new service delivery models currently being employed across the Region. The case studies directly relate to the priority areas in ... 2020 and exemplify the types of activities needed to fully implement the objectives within the Strategic Directions framework.
The purpose of this report is to provide an overview of the issues in regulating and managing international emergency in a selection of large and s...
Summary Report on the Comprehensive Study
This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility ... their authors and do not necessarily reflect the views of USAID or the United States Government.
This report presents key findings from a study carried out on the ‘Mainstreaming quality of care in empanelled hospitals under PMJAY’. It provides a detailed analysis of current coverage and per...
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline
This report, published in conjunction with a summary overview of results of rounds 1–8, is the eighth and final report in a series of laboratory...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels ... disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest imaging in different situations, remarks are provided to describe the circumstances under which each recommendation would benefit patients. The guide also includes implementation considerations for different settings, provides suggestions for impact monitoring and evaluation and identifies knowledge gaps meriting further research.
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school drug-use-prevention programmes...
This report - the largest of its kind to date - draws on the experiences of over 8,500 women and 300 health professionals across eight countries. I...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safe...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as ... 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly replacing Delta worldwide – was considered Omicron has a substantial growth advantage, higher secondary attack rates and a higher observed reproduction number than Delta.
There is now significant evidence that immune evasion contributes to the rapid spread of Omicron. Other factors may be a shorter
serial interval (by about 0.8 to 1.2 days compared to Delta) and potential increased intrinsic transmission fitness . There is
growing evidence that with Omicron, there is lower vaccine effectiveness (VE) against infection and symptomatic disease soon after vaccination compared to Delta. There is also evidence of accelerated waning of VE over time of the primary series against infection and symptomatic disease for the studied vaccines. Further studies are required to better understand the drivers of transmission and declining incidence in various settings. These factors include the intrinsic transmission fitness properties of the virus, degree of immune evasion, vaccination coverage and level of vaccine-derived and post-infection immunity, levels of social mixing and degree of application of public health and social measures (PHSM).
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically impor...
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health c...
21 August 2020
This guidance provides specific considerations for the use of non-medical masks, also known as fabric masks, by children as a means for source control in the context of the current C...
This recommendation is an update of one of the 49 recommendations that were published in the WHO recommendations on antenatal care for a positive pregnancy experience. The recommendation was develop...
